SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies informs about board meeting

19 Jan 2026 Evaluate

Venus Remedies has informed that the meeting of Board of Directors is scheduled to be held on 29th January 2026: 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the period ended on 31st December 2025. 2. Any other business with the permission of Chair. Pursuant to the provisions of Prevention of Insider Trading regulations, the trading window for trading in Company's shares by Designated Persons has been closed from January 01, 2026 till 48 hours from the declaration of financial results.

The above information is a part of company’s filings submitted to BSE.

Venus Remedies Share Price

1039.95 45.80 (4.61%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×